title: Delayed tacrolimus is safe with basiliximab induction therapy.
authors.forename: Kang H
authors.initials: KH
authors.lastname: Lee
authors.forename: Maureen
authors.initials: M
authors.lastname: Da Costa
authors.forename: Seng-Gee
authors.initials: SG
authors.lastname: Lim
authors.forename: Kai-Chah
authors.initials: KC
authors.lastname: Tan
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000077552:Basiliximab; D002102:Cadaver; D004334:Drug Administration Schedule; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000379:methods*; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011184:Postoperative Period; D011993:Recombinant Fusion Proteins; D012449:Safety; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*; D014019:Tissue Donors
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab; D016559:Tacrolimus; D008775:Methylprednisolone